News & Updates

Ursodeoxycholic acid may prevent post-gastrectomy gallstones in gastric cancer

07 Jul 2020 by

A daily dose of ursodeoxycholic acid (UDCA) may prevent gallstone formation in patients with gastric cancer who have undergone gastrectomy, suggested results of the PEGASUS-D trial.

Ursodeoxycholic acid may prevent post-gastrectomy gallstones in gastric cancer

07 Jul 2020

Ipragliflozin shows benefits for T2D patients with NAFLD

06 Jul 2020 by

Long-term use of ipragliflozin improves obesity, glycaemic control, and hepatic outcomes in patients with type 2 diabetes (T2D) who developed nonalcoholic fatty liver disease (NAFLD), a study shows.

Ipragliflozin shows benefits for T2D patients with NAFLD

06 Jul 2020

Frailty triples risk of death in IBD patients

06 Jul 2020

Frailty is common in patients with inflammatory bowel disease (IBD), with the prevalence increasing with age, and is associated with a threefold higher likelihood of death, a study has found.

Frailty triples risk of death in IBD patients

06 Jul 2020

News & Updates

Filter by Specialty:

Specialty:

Ursodeoxycholic acid may prevent post-gastrectomy gallstones in gastric cancer

Ursodeoxycholic acid may prevent post-gastrectomy gallstones in gastric cancer

Ipragliflozin shows benefits for T2D patients with NAFLD

Ipragliflozin shows benefits for T2D patients with NAFLD

Frailty triples risk of death in IBD patients

Frailty triples risk of death in IBD patients